Human Drugs View

Product Information DR-XY48407_PI_01.pdf
Registration Number DR-XY48407
Generic Name Indacaterol Acetate + Glycopyrronium Bromide + Mometasone Furoate
Brand Name Enerzair Breezhaler
Dosage Strength 150mcg/50mcg/80mcg
Dosage Form Powder for inhalation in Hard capsules
Classification Prescription Drug (RX)
Pharmacologic Category Selective Beta-2 adrenoreceptor Agonist/ Anticholinergic/ Corticosteroid
Packaging PA/AL/PVC-PET/AL Blister Pack x 10's (Box of 10's + 1 Inhaler) (Box of 30's + 1 Inhaler)
Manufacturer Novartis Pharma Stein AG
Country of Origin Switzerland
Trader N/A
Importer Novartis Healthcare Philippines, Inc.
Distributor Novartis Healthcare Philippines, Inc.
Application Type Monitored Release
Issuance Date 07 October 2022
Expiry Date 07 October 2025